Citizens Financial Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-19
Closed -$1K 296
2020
Q2
$1K Buy
+19
New +$550 ﹤0.01% 1021
2017
Q3
Sell
-12
Closed 509
2017
Q2
$0 Sell
12
-99
-89% -$3.74K ﹤0.01% 525
2017
Q1
$4K Sell
111
-127
-53% -$4.95K ﹤0.01% 535
2016
Q4
$9K Hold
238
﹤0.01% 451
2016
Q3
$8K Sell
238
-12
-5% -$420 ﹤0.01% 472
2016
Q2
$8K Buy
250
+97
+63% +$2.97K ﹤0.01% 487
2016
Q1
$5K Buy
153
+66
+76% +$1.76K ﹤0.01% 506
2015
Q4
$4K Buy
+87
New +$2.71K ﹤0.01% 570

Other funds holding AVNS

Citizens Financial Group's AVNS Position: Q3 2020 in Review

Citizens Financial Group sold out of Avanos Medical (AVNS) in Q3 2020, closing a stake of 19 shares — an estimated $1K sold.

Citizens Financial Group first reported a position in AVNS in Q4 2015 and held it in 8 quarters. The position peaked at $9K in Q4 2016. 272 funds tracked by Wall St. Rank hold AVNS as of Q3 2020.

  • Citizens Financial Group reported no remaining Avanos Medical position as of Q3 2020 after selling out during the quarter.
  • Citizens Financial Group sold 19 Avanos Medical shares in Q3 2020, an estimated $1K.
  • Citizens Financial Group first reported a position in Avanos Medical in Q4 2015 and held it in 8 quarters.
  • Citizens Financial Group's Avanos Medical position peaked at $9K in Q4 2016.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2020.

Based on Citizens Financial Group's 13F filing for Q3 2020, filed 12 Nov 2020.